Skip to main navigation
Skip to search
Skip to main content
Penn State Home
Help & FAQ
Link opens in a new tab
Search content at Penn State
Home
Researchers
Research output
Research units
Equipment
Grants & Projects
Prizes
Activities
Historical overview of pediatric HSCT
Valerie Brown
Department of Pediatrics
Penn State Cancer Institute
Cancer Institute, Experimental Therapeutics
Division of Hematology and Oncology
Research output
:
Chapter in Book/Report/Conference proceeding
›
Chapter
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Historical overview of pediatric HSCT'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Historical Overview
100%
Hematopoietic Stem Cell Transplantation
100%
Pediatric Hematopoietic Stem Cell Transplantation
100%
Treatment Modalities
27%
HLA-matched Donor
27%
Immunology
18%
Leukemia
18%
Transplantation
18%
Allogeneic Bone Marrow Transplantation
18%
Primary Immunodeficiency
18%
Malignant Disorders
18%
Mismatched Related Donor
18%
Matched Unrelated Donor
18%
Refractory Acute Leukemia
18%
Irradiation
9%
Calcineurin Inhibitors
9%
Pediatric Patients
9%
Conditioning Regimen
9%
Long-term Survivors
9%
Adult Patients
9%
Leukemia Patients
9%
Acute Leukemia
9%
Bone Marrow
9%
Engraftment
9%
Second Remission
9%
Human Trials
9%
Umbilical Cord Blood
9%
Graft-versus-host Disease (GvHD)
9%
Detonation
9%
Identical Twins
9%
Clinical Perspective
9%
Allogeneic HSCT
9%
World War II
9%
Hematopoietic Stem Cells
9%
Active Disease
9%
Nonmalignant
9%
Supportive Care
9%
Haploidentical Donor
9%
Atomic Bomb
9%
Graft-versus-host Disease Prophylaxis
9%
First Remission
9%
Stem Cell Source
9%
Atomic Age
9%
Severe Aplastic Anemia
9%
Clinical Report
9%
Medicine and Dentistry
Pediatrics
100%
Hematopoietic Stem Cell Transplantation
100%
Acute Leukemia
27%
Treatment Modality
27%
Immunology
18%
Leukemia
18%
Graft Versus Host Reaction
18%
Bone Marrow Transplantation
18%
Immune Deficiency
18%
Diseases
18%
Supportive Care
9%
Engraftment
9%
Allogeneic Hematopoietic Stem Cell Transplantation
9%
Calcineurin Inhibitor
9%
Aplastic Anemia
9%
Cord Blood
9%
Monozygotic Twins
9%
Alternative Donor
9%
Hematopoietic Cell
9%
Patient with Hematopoietic Stem Cell Transplantation
9%
Immunology and Microbiology
Hematopoietic Stem Cell Transplantation
100%
Immunology
16%
Bone Marrow Transplantation
16%
Graft-Versus-Host Disease
16%
Primary Immunodeficiency
16%
Engraftment
8%
Allogeneic Hematopoietic Stem Cell Transplantation
8%
Hematopoietic Cell
8%
Umbilical Cord Blood
8%
Aplastic Anemia
8%
Monozygotic Twins
8%